Banco Santander, S.A. Abb Vie Inc. Transaction History

Banco Santander, S.A.

$8.47 Billion
Q3 2024

A detailed history of Banco Santander, S.A. transactions in Abb Vie Inc. stock. As of the latest transaction made, Banco Santander, S.A. holds 64,537 shares of ABBV stock, worth $11.9 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

64,537

Previous 102,269 36.89%

Holding current value

$11.9 Million

Previous $17.5 Million 27.35%

% of portfolio

0.15%

Previous 0.22%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$163.84 - $199.33 $6.18 Million - $7.52 Million	-37,732 Reduced 36.89%	64,537 $12.7 Million
Q2 2024 Jul 29, 2024	SELL	$154.79 - $180.76 $10.9 Million - $12.8 Million	-70,702 Reduced 40.88%	102,269 $17.5 Million
Q1 2024 May 10, 2024	SELL	$159.82 - $182.1 $18 Million - $20.5 Million	-112,480 Reduced 39.4%	172,971 $31.5 Million
Q4 2023 Feb 09, 2024	BUY	$137.6 - $154.97 $2.55 Million - $2.87 Million	18,531 Added 6.94%	285,451 $44.2 Million
Q3 2023 Nov 08, 2023	BUY	$133.59 - $154.65 $1.6 Million - $1.85 Million	11,958 Added 4.69%	266,920 $39.8 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $10.8 Million - $13.4 Million	81,520 Added 47.0%	254,962 $34.4 Million
Q1 2023 May 10, 2023	SELL	$144.61 - $166.54 $256,971 - $295,941	-1,777 Reduced 1.01%	173,442 $27.6 Million
Q4 2022 Feb 13, 2023	SELL	$138.31 - $165.87 $1.67 Million - $2.01 Million	-12,094 Reduced 6.46%	175,219 $28.3 Million
Q3 2022 Nov 08, 2022	SELL	$134.21 - $153.93 $2.14 Million - $2.46 Million	-15,979 Reduced 7.86%	187,313 $25.1 Million
Q2 2022 Jul 28, 2022	SELL	$137.62 - $174.96 $586,674 - $745,854	-4,263 Reduced 2.05%	203,292 $31.1 Million
Q1 2022 May 09, 2022	SELL	$131.98 - $163.75 $3.09 Million - $3.84 Million	-23,448 Reduced 10.15%	207,555 $33.6 Million
Q4 2021 Feb 09, 2022	BUY	$107.43 - $135.93 $1.24 Million - $1.57 Million	11,559 Added 5.27%	231,003 $31.3 Million
Q3 2021 Nov 08, 2021	BUY	$106.4 - $120.78 $4.15 Million - $4.71 Million	38,968 Added 21.59%	219,444 $23.7 Million
Q2 2021 Jul 29, 2021	BUY	$105.21 - $117.21 $2.51 Million - $2.8 Million	23,860 Added 15.23%	180,476 $20.3 Million
Q1 2021 May 10, 2021	BUY	$102.3 - $112.62 $2.85 Million - $3.13 Million	27,828 Added 21.61%	156,616 $16.9 Million
Q4 2020 Feb 12, 2021	BUY	$80.49 - $108.67 $928,774 - $1.25 Million	11,539 Added 9.84%	128,788 $13.8 Million
Q3 2020 Nov 09, 2020	SELL	$85.91 - $100.83 $75,944 - $89,133	-884 Reduced 0.75%	117,249 $10.3 Million
Q2 2020 Aug 05, 2020	BUY	$73.37 - $98.18 $7.53 Million - $10.1 Million	102,689 Added 664.91%	118,133 $11.6 Million
Q1 2020 May 11, 2020	BUY	$64.5 - $97.79 $289,153 - $438,392	4,483 Added 40.9%	15,444 $1.18 Million
Q4 2019 Feb 07, 2020	SELL	$72.13 - $90.25 $496,615 - $621,371	-6,885 Reduced 38.58%	10,961 $970,000
Q3 2019 Nov 06, 2019	BUY	$62.98 - $75.72 $319,371 - $383,976	5,071 Added 39.69%	17,846 $1.35 Million
Q2 2019 Aug 07, 2019	SELL	$65.7 - $83.98 $59,261 - $75,749	-902 Reduced 6.6%	12,775 $929,000
Q1 2019 May 13, 2019	SELL	$77.14 - $90.79 $186,447 - $219,439	-2,417 Reduced 15.02%	13,677 $1.1 Million
Q4 2018 Feb 12, 2019	SELL	$77.85 - $96.01 $168,389 - $207,669	-2,163 Reduced 11.85%	16,094 $1.48 Million
Q3 2018 Nov 13, 2018	BUY	$88.91 - $98.84 $104,735 - $116,433	1,178 Added 6.9%	18,257 $1.73 Million
Q2 2018 Aug 14, 2018	SELL	$89.78 - $106.23 $22.9 Million - $27.1 Million	-254,709 Reduced 93.72%	17,079 $1.58 Million
Q1 2018 May 14, 2018	BUY	$92.01 - $123.21 $25 Million - $33.5 Million	271,788 New	271,788 $25.7 Million

Others Institutions Holding ABBV

# of Institutions

3,891

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $325B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Banco Santander, S.A., based on Form 13F filings with the SEC.

News

Stay updated on Banco Santander, S.A. with notifications on news.

Account

Banco Santander, S.A. Abb Vie Inc. Transaction History